<DOC>
	<DOCNO>NCT00586963</DOCNO>
	<brief_summary>This study do two reason : - To learn effect ( good bad ) esomeprazole ( FDA approve drug reflux esophagitis ) esophagus take correctly . - To learn quality life change ( good bad ) may experience medication .</brief_summary>
	<brief_title>Proton Pump Inhibitor ( PPI ) Therapy Newly Diagnosed Esophagitis</brief_title>
	<detailed_description>The plan 50 people take part study Mayo Clinic Rochester . This research study look people new condition call erosive reflux esophagitis . Esophagitis define mucosal damage produce abnormal reflux gastric content esophagus . Acid reflux , time , wear away erode lining esophagus . This condition call erosive esophagitis . The treat physician may start prescription strength acid reduce group medication call Proton Pump Inhibitors ( PPI ) . PPI medication provide 24-hour relief painful heartburn symptom help heal erosion esophagus acid reflux may cause .</detailed_description>
	<mesh_term>Esophagitis</mesh_term>
	<mesh_term>Esophagitis , Peptic</mesh_term>
	<mesh_term>Proton Pump Inhibitors</mesh_term>
	<criteria>Age 18 old Have either mildtomoderate erosive reflux esophagitis Meet criterion GERD symptom . Patients already esomeprazole therapy , previously fail respond esomeprazole , intolerant PPI therapy . Patients expect travel outside United States initial 8 week PPI therapy . Pregnant woman exclude PPI 's thought safe fetus ( Pregnancy Category C ) . Children young 18 year age exclude . Other vulnerable population , diminish mental acuity , exclude .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>Erosive Esophagitis</keyword>
	<keyword>Reflux Esophagitis</keyword>
	<keyword>GERD</keyword>
</DOC>